SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-20-000502
Filing Date
2020-02-14
Accepted
2020-02-14 13:13:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da109488034_02142020.htm SC 13D/A 203014
2 LETTER TO THE BOARD, DATED FEBRUARY 14, 2020 ex991to13da109488034_021420.htm EX-99.1 10587
  Complete submission text file 0000921895-20-000502.txt   215498
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87950 | Film No.: 20617265
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1370 BROADWAY 5TH FLOOR NEW YORK NY 10018
Business Address 1370 BROADWAY 5TH FLOOR NEW YORK NY 10018 (212) 321-0048
ENGINE CAPITAL, L.P. (Filed by) CIK: 0001580320 (see all company filings)

IRS No.: 364755478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A